{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T22:36:40Z","timestamp":1769639800402,"version":"3.49.0"},"reference-count":38,"publisher":"American Academy of Pediatrics (AAP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2003,11,1]]},"abstract":"<jats:p>Objective. Patent ductus arteriosus (PDA), a common finding among premature infants, is conventionally treated by intravenous indomethacin. Intravenous ibuprofen was recently shown to be as effective and to have fewer adverse reactions in preterm infants. If equally effective, then oral ibuprofen for PDA closure would have several important advantages over the intravenous route. This study was designed to determine whether oral ibuprofen treatment is efficacious and safe in closure of a PDA in premature infants with respiratory distress syndrome.<\/jats:p><jats:p>Methods. Twenty-two preterm newborns (gestational age: 27.5 \u00b1 1.75 [range: 23.9\u201331 weeks]; weight: 979 \u00b1 266 [range: 380-1500 g]) with PDA and respiratory distress syndrome were studied prospectively. They received oral ibuprofen suspension 10 mg\/kg\/body weight for the first dose, followed at 24-hour intervals by 2 additional doses of 5 mg\/kg each, if needed, starting on the second day of life. Echocardiography was performed before treatment and 24 hours after each dose. Every child underwent cranial ultrasonography before and after each ibuprofen dose. The rate of ductal closure, the need for additional treatment, side effects, complications, and the infants\u2019 clinical courses were recorded.<\/jats:p><jats:p>Results. Ductal closure was achieved in all newborns except for 1 (95.5%), in whom clinically nonsignificant ductal shunting persisted. No infant required surgical ligation of the ductus. There was no reopening of the ductus after closure had been achieved. Fourteen newborns were treated with 1 dose of ibuprofen, 6 were treated with 2 doses, and the remaining 2 were treated with 3 doses. The survival rate at 1 month was 86.4% (19 of 22). Three (13.6%) infants died from the following causes: 1 who was born at 24 weeks\u2019 gestation with a birth weight of 380 g died as a result of extreme prematurity complications, necrotizing enterocolitis, and low birth weight; 1 died as a result of Candida sepsis; and the third died as a result of Klebsiella sepsis. Intraventricular hemorrhage was observed in 7 infants. The classification was changed from grade 2 to grade 3 in 1 and from grade 0 to grade 1 or higher in 3 others. The rate of survival to discharge was 86.4% (19 of 22). No bronchopulmonary dysplasia was observed in the study group, and there was no case of tendency to bleed. There were no significant differences in the levels of serum creatinine before and after treatment with oral ibuprofen.<\/jats:p><jats:p>Conclusions. Oral ibuprofen suspension may be an effective and safe alternative for PDA closure in premature infants with PDA. However, larger comparative studies are warranted.<\/jats:p>","DOI":"10.1542\/peds.112.5.e354","type":"journal-article","created":{"date-parts":[[2004,8,14]],"date-time":"2004-08-14T00:43:47Z","timestamp":1092444227000},"page":"e354-e354","source":"Crossref","is-referenced-by-count":45,"title":["Closure of Patent Ductus Arteriosus With Oral Ibuprofen Suspension in Premature Newborns: A Pilot Study"],"prefix":"10.1542","volume":"112","author":[{"given":"Eli","family":"Heyman","sequence":"first","affiliation":[{"name":"Neonatal Intensive Care Unit"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iris","family":"Morag","sequence":"additional","affiliation":[{"name":"Neonatal Intensive Care Unit"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Batash","sequence":"additional","affiliation":[{"name":"Neonatal Intensive Care Unit"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rimona","family":"Keidar","sequence":"additional","affiliation":[{"name":"Neonatal Intensive Care Unit"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaul","family":"Baram","sequence":"additional","affiliation":[{"name":"Pediatric Cardiology Unit"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matitiahu","family":"Berkovitch","sequence":"additional","affiliation":[{"name":"Clinical Pharmacology and Toxicology Unit, Assaf Harofeh Medical Center, Zerifin, affiliated to the Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[2003,11,1]]},"reference":[{"key":"2021120820290740200_R1","doi-asserted-by":"crossref","unstructured":"The Vermont-Oxford Trials Network: Very low birth weight outcomes for 1990. Pediatrics.1993;91:540\u2013545","DOI":"10.1542\/peds.91.3.540"},{"key":"2021120820290740200_R2","doi-asserted-by":"crossref","unstructured":"Cotton RB, Stahlman MT, Bender HW, Graham TP, Catterton WZ, Kovar I. Randomized trial of early closure of symptomatic patent ductus arteriosus in small preterm infants. J Pediatr.1978;93:647\u2013651","DOI":"10.1016\/S0022-3476(78)80910-X"},{"key":"2021120820290740200_R3","doi-asserted-by":"crossref","unstructured":"Gersony WM, Peckham GJ, Ellison RC, Miettinen OS, Nadas AS. Effects of indomethacin in premature infants with patent ductus arteriosus: results of a national collaborative study. J Pediatr.1983;102:895\u2013906","DOI":"10.1016\/S0022-3476(83)80022-5"},{"key":"2021120820290740200_R4","doi-asserted-by":"crossref","unstructured":"Cotton RB, Stahlman MT, Kovar I, Catterton WZ. Medical management of small preterm infants with symptomatic patent ductus arteriosus. J Pediatr.1979;2:467\u2013473","DOI":"10.1016\/S0022-3476(78)80451-X"},{"key":"2021120820290740200_R5","doi-asserted-by":"crossref","unstructured":"Stefano JL, Abbasi S, Pearlman SA, Spear ML, Esterly KL, Bhutani VK. Closure of the ductus arteriosus with indomethacin in ventilated neonates with respiratory distress syndrome: effects on pulmonary compliance and ventilation. Am Rev Respir Dis.1991;143:236\u2013239","DOI":"10.1164\/ajrccm\/143.2.236"},{"key":"2021120820290740200_R6","doi-asserted-by":"crossref","unstructured":"Krueger E, Mellander M, Bratton D, Cotton R. Prevention of symptomatic ductus arteriosus with single dose of indomethacin. J Pediatr.1987;111:749\u2013754","DOI":"10.1016\/S0022-3476(87)80262-7"},{"key":"2021120820290740200_R7","doi-asserted-by":"crossref","unstructured":"Hammerman C, Glaser J, Schimmel MS, Ferber B, Kaplan M, Eidelman AI. Continuous versus multiple rapid infusion of indomethacin: effects on cerebral blood flow velocity. Pediatrics.1995;95:244\u2013248","DOI":"10.1542\/peds.95.2.244"},{"key":"2021120820290740200_R8","doi-asserted-by":"crossref","unstructured":"Van Bel F, Guit GL, Schipper J, van de Bor M, Baan J. Indomethacin-induced changes in renal blood flow velocity waveform in premature infants investigated with color Doppler imaging. J Pediatr.1991;118:621\u2013626","DOI":"10.1016\/S0022-3476(05)83391-8"},{"key":"2021120820290740200_R9","doi-asserted-by":"crossref","unstructured":"Coombs RC, Morgan MEI, Durbin GM, Booth IW, McNeisc AS. Gut blood flow velocities in newborn: effects of patent ductus arteriosus and parenteral indomethacin. Arch Dis Child.1990;65:1067\u20131071","DOI":"10.1136\/adc.65.10_Spec_No.1067"},{"key":"2021120820290740200_R10","doi-asserted-by":"crossref","unstructured":"Van Bel F, van Zoeren D, Schipper J, Guit GL, Baan J. Effect of indomethacin on superior mesenteric artery blood flow velocity in preterm infants. J Pediatr.1990;116:965\u2013970","DOI":"10.1016\/S0022-3476(05)80662-6"},{"key":"2021120820290740200_R11","doi-asserted-by":"crossref","unstructured":"Van Bel F, van De Bor M, Stijnen T, Baan J, Ruys JH. Cerebral blood flow velocity changes in preterm infants after a single dose of indomethacin: duration of its effects. Pediatrics.1989;84:802\u2013807","DOI":"10.1542\/peds.84.5.802"},{"key":"2021120820290740200_R12","doi-asserted-by":"crossref","unstructured":"Pryds O, Greisen G, Johansen K. Indomethacin and cerebral blood flow in preterm infants treated for patent ductus arteriosus. Eur J Pediatr.1988;147:315\u2013316","DOI":"10.1007\/BF00442705"},{"key":"2021120820290740200_R13","doi-asserted-by":"crossref","unstructured":"Mardoum R, Bejar R, Merritt A, Berry C. Controlled study of the effects of indomethacin on cerebral blood flow velocities in newborn infants. J Pediatr.1991;118:112\u2013115","DOI":"10.1016\/S0022-3476(05)81860-8"},{"key":"2021120820290740200_R14","doi-asserted-by":"crossref","unstructured":"Laudignon N, Chemtob S, Bard H, Aranda J. Effect of indomethacin on the cerebral blood flow velocity of premature infants. Biol Neonate.1988;54:254\u2013262","DOI":"10.1159\/000242860"},{"key":"2021120820290740200_R15","doi-asserted-by":"crossref","unstructured":"Coceani F, White E, Bodach E, Olley PM. Age-dependent changes in the response of the lamb ductus arteriosus to oxygen and ibuprofen. Can J Physiol Pharmacol.1979;57:825\u2013831","DOI":"10.1139\/y79-126"},{"key":"2021120820290740200_R16","doi-asserted-by":"crossref","unstructured":"Varvarigou N, Bardin CL, Beharry K, Chemtob S, Papageorgiou A, Aranda JV. Early ibuprofen administration to prevent patent ductus arteriosus in premature infants. JAMA.1996;275:539\u2013544","DOI":"10.1001\/jama.275.7.539"},{"key":"2021120820290740200_R17","doi-asserted-by":"crossref","unstructured":"Van Overmeire B, Smets K, Lecoutere D, van de Broek H, Weyler J. A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus. N Engl J Med.2000;343:674\u2013681","DOI":"10.1056\/NEJM200009073431001"},{"key":"2021120820290740200_R18","doi-asserted-by":"crossref","unstructured":"Chemtob S, Laudignon N, Beharry K, Rex J, Wolfe, Varma DR, Aranda JV. Effects of prostaglandins and indomethacin on cerebral blood flow and oxygen consumption of conscious newborn piglets. Dev Pharmacol Ther.1990;14:1\u201314","DOI":"10.1159\/000480933"},{"key":"2021120820290740200_R19","doi-asserted-by":"crossref","unstructured":"Chemtob S, Beharry K, Rex J, Varma DR, Aranda JV. Prostanoids determine the range of cerebral blood flow autoregulation of newborn piglets. Stroke.1990;21:777\u2013784","DOI":"10.1161\/01.STR.21.5.777"},{"key":"2021120820290740200_R20","doi-asserted-by":"crossref","unstructured":"Chemtob S, Beharry K, Barna T, Varma DR, Aranda JV. Differences in the effect in the newborn piglet of various nonsteroidal antiinflammatory drugs on cerebral blood flow but not on cerebrovascular prostaglandins. Pediatr Res.1991;30:106\u2013111","DOI":"10.1203\/00006450-199107000-00021"},{"key":"2021120820290740200_R21","doi-asserted-by":"crossref","unstructured":"Mosca F, Bray M, Lattanzio M, Fumagalli M, Tosetto C. Comparative evaluation of the effects of indomethacin and ibuprofen on cerebral perfusion and oxygenation in preterm infants with patent ductus arteriosus. J Pediatr.1997;131:549\u2013554","DOI":"10.1016\/S0022-3476(97)70060-X"},{"key":"2021120820290740200_R22","doi-asserted-by":"crossref","unstructured":"Malcolm DD, Segar JL, Robillard E, Chemtob S. Indomethacin compromises hemodynamics during positive-pressure ventilation, independently of prostanoids. J Appl Physiol.1993;74:1672\u20131678","DOI":"10.1152\/jappl.1993.74.4.1672"},{"key":"2021120820290740200_R23","doi-asserted-by":"crossref","unstructured":"Johnson GL, Breat GL, Gewitz MH, et al. Echocardiographic characteristics of premature infants with patent ductus arteriosus. Pediatrics.1983;72:864\u2013871","DOI":"10.1542\/peds.72.6.864"},{"key":"2021120820290740200_R24","doi-asserted-by":"crossref","unstructured":"Papile LS, Burstein J, Burstein R, Keffler H. Incidence and evolution of the subependymal intraventricular hemorrhage: a study of infants weighing less than 1500 grams. J Pediatr.1978;92:529\u2013534","DOI":"10.1016\/S0022-3476(78)80282-0"},{"key":"2021120820290740200_R25","doi-asserted-by":"crossref","unstructured":"Shankaran S, Slovis TL, Bedard MP, Poland RL. Sonographic classification of intracranial hemorrhage: a prognostic indicator of mortality, morbidity, and short-term neurologic outcome. J Pediatr.1982;100:469\u2013475","DOI":"10.1016\/S0022-3476(82)80462-9"},{"key":"2021120820290740200_R26","doi-asserted-by":"crossref","unstructured":"de Vries LS, Eken P, Dubowitz LM. The spectrum of leukomalacia using cranial ultrasound. Behav Brain Res.1992;49:1\u20136","DOI":"10.1016\/S0166-4328(05)80189-5"},{"key":"2021120820290740200_R27","doi-asserted-by":"crossref","unstructured":"Shennan AT, Dunn MS, Ohlsson A, Lennox K, Hoskin EM. Abnormal pulmonary outcome in premature infants: prediction from oxygen requirement in the neonatal period. Pediatrics.1988;82:527\u2013532","DOI":"10.1542\/peds.82.4.527"},{"key":"2021120820290740200_R28","doi-asserted-by":"crossref","unstructured":"Mahony L, Carnero V, Brett C, Heymann MA, Clyman RI. Prophylactic indomethacin therapy for patent ductus arteriosus in very low birth weight infants. N Engl J Med.1982;306:506\u2013510","DOI":"10.1056\/NEJM198203043060903"},{"key":"2021120820290740200_R29","doi-asserted-by":"crossref","unstructured":"Van Overmeire B, Touw D, Schepens PJC, Kearns GL, van den Anker J. Ibuprofen pharmacokinetics in preterm infants with patent ductus arteriosus. Clin Pharmacol Ther.2001;70:336\u2013343","DOI":"10.1067\/mcp.2001.118453"},{"key":"2021120820290740200_R30","doi-asserted-by":"crossref","unstructured":"Kauffman RE, Nelson MV. Effect of age on ibuprofen pharmacokinetics and antipyretic response. J Pediatr.1992;121:969\u2013973","DOI":"10.1016\/S0022-3476(05)80354-3"},{"key":"2021120820290740200_R31","doi-asserted-by":"crossref","unstructured":"Kelley MT, Walson PD, Edge JH, Cox S, Mortensen ME. Pharmacokinetics and pharmacodynamics of ibuprofen isomers and acetaminophen in febrile children. Clin Pharmacol Ther.1992;52:181\u2013189","DOI":"10.1038\/clpt.1992.128"},{"key":"2021120820290740200_R32","doi-asserted-by":"crossref","unstructured":"Raju NV, Bharadwaj RA, Thomas R, Konduri GG. Ibuprofen use to reduce the incidence and severity of bronchopulmonary dysplasia: a pilot study. J Perinatol.2000;1:13\u201316","DOI":"10.1038\/sj.jp.7200296"},{"key":"2021120820290740200_R33","doi-asserted-by":"crossref","unstructured":"Lesko SM, Mitchell AA. An assessment of the safety of pediatric ibuprofen: a practitioner-based randomized clinical trial. JAMA.1995;273:929\u2013933","DOI":"10.1001\/jama.273.12.929"},{"key":"2021120820290740200_R34","doi-asserted-by":"crossref","unstructured":"Lesko SM, Mitchell AA. The safety of acetaminophen and ibuprofen among children younger than two years old. Pediatrics.1999;104(4). Available at: http:\/\/www.pediatrics.org\/cgi\/content\/full\/104\/4\/e39","DOI":"10.1542\/peds.104.4.e39"},{"key":"2021120820290740200_R35","unstructured":"Devine ST, Rosenberg HK, Kumar LS, Bhandari V. Esophageal perforation in the preterm newborn: case report and review of the literature. Conn Med.2002;66:131\u2013135"},{"key":"2021120820290740200_R36","doi-asserted-by":"crossref","unstructured":"Ojala R, Ruuska T, Karikoski R, Ikonen RS, Tammela O. Gastroesophageal endoscopic findings and gastrointestinal symptoms in preterm neonates with and without perinatal indomethacin exposure. J Pediatr Gastroenterol Nutr.2001;32:182\u2013188","DOI":"10.1097\/00005176-200102000-00017"},{"key":"2021120820290740200_R37","doi-asserted-by":"crossref","unstructured":"Vanhesebrouck P, Thiery M, Leroy JG, et al. Oligohydramnios, renal insufficiency, and ileal perforation in preterm infants after intrauterine exposure to indomethacin. J Pediatr.1988;113:738\u2013743","DOI":"10.1016\/S0022-3476(88)80392-5"},{"key":"2021120820290740200_R38","doi-asserted-by":"crossref","unstructured":"Gournay V, Savagner C, Thiriez G, Kuster A, Roze JC. Pulmonary hypertension after ibuprofen prophylaxis in very preterm infants. Lancet.2002;359:1486\u20131488","DOI":"10.1016\/S0140-6736(02)08424-6"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/112\/5\/e354\/1002822\/pe110300e354.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/112\/5\/e354\/1002822\/pe110300e354.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T05:35:43Z","timestamp":1682746543000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/112\/5\/e354\/28768\/Closure-of-Patent-Ductus-Arteriosus-With-Oral"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,11,1]]},"references-count":38,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2003,11,1]]},"published-print":{"date-parts":[[2003,11,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.112.5.e354","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,11,1]]}}}